Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in cats
A method is described for the treatment of systemic diseases in cats. A composition is administered to a cat, where the composition includes a therapeutically effective amount of angiotensin II receptor 1 (AT-1) antagonist (sartan).
Saved in:
| Main Authors | , , |
|---|---|
| Format | Patent |
| Language | English |
| Published |
24.04.2018
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | A method is described for the treatment of systemic diseases in cats. A composition is administered to a cat, where the composition includes a therapeutically effective amount of angiotensin II receptor 1 (AT-1) antagonist (sartan). |
|---|---|
| AbstractList | A method is described for the treatment of systemic diseases in cats. A composition is administered to a cat, where the composition includes a therapeutically effective amount of angiotensin II receptor 1 (AT-1) antagonist (sartan). |
| Author | Lang, Ingo Sent, Ulrike D Stark, Marcus |
| Author_xml | – fullname: Stark, Marcus – fullname: Lang, Ingo – fullname: Sent, Ulrike D |
| BookMark | eNqNjLsKwkAQRbfQwtc_zA_YaCy2VFFMrdZhWG-SBTO77AyCf28EP8DqcA6XO3cTSYKZa_bSxWQQjUJ1TQUB2VIhFuMuSVSjdlTrQbngBbGYhL6lgG0YnVJL-lbDEAM9ooIVSuNdYNOlm7b8VKx-XDg6n27Hyxo5NdDMAQJr7lfvK-931WGz_WPyAX0EPuU |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| ExternalDocumentID | US9949954B2 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_US9949954B23 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 13:07:41 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_US9949954B23 |
| Notes | Application Number: US201715411062 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180424&DB=EPODOC&CC=US&NR=9949954B2 |
| ParticipantIDs | epo_espacenet_US9949954B2 |
| PublicationCentury | 2000 |
| PublicationDate | 20180424 |
| PublicationDateYYYYMMDD | 2018-04-24 |
| PublicationDate_xml | – month: 04 year: 2018 text: 20180424 day: 24 |
| PublicationDecade | 2010 |
| PublicationYear | 2018 |
| RelatedCompanies | Boehringer Ingelheim Vetmedica GmbH |
| RelatedCompanies_xml | – name: Boehringer Ingelheim Vetmedica GmbH |
| Score | 3.1475074 |
| Snippet | A method is described for the treatment of systemic diseases in cats. A composition is administered to a cat, where the composition includes a therapeutically... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| Title | Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in cats |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180424&DB=EPODOC&locale=&CC=US&NR=9949954B2 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFfWmVbG-mIPkFmza7esQxCYtrdAHtpXeSjfZLblsgon4952JafWit2UXht2Beex-M98CPMhQMwucYweBUAwzbuxurRbajpS6o8gjSsW9w-NJa7gUL6vmqgTRrhcm5wn9zMkRyaICsvcs99fJzyOWn9dWpo8yoqn4abBwfau4HTsdRvIsv-f2Z1N_6lme5y7n1uTV7TIJS1P0yFsfcBbNNPv9tx43pSS_I8rgFA5nJMxkZ1BSpgLH3u7jtQocjQu8m4aF6aXnsH422yjO680NjkZInkoldGFGUs1mGzMBLlICipTQYVLwMsUGeWZXS46xxm_m5ijAAplJkcTRidMLwEF_4Q1t2ul6r5X1cr4_U-MSyiY26gqw3RKODEU3UFqIgNtqw4Yja5uw3qwLrXUVqn-Kuf5n7QZOWL2Mo9TFLZSz9w91R-E4k_e5Ir8Abu-Sew |
| link.rule.ids | 230,309,786,891,25594,76903 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8MwDLamgRg3GCA2Xjmg3irWLXsdKsTaTS3sJbah3aqlTaZe0ooW8fdxQje4wC1KJCuxZDvOZ38BuGeRUCxwlhmGlCuYcWP2G43ItBgTPY4ekXHVOzyZdrwVfV631yWId70wmif0U5MjokWFaO-59tfpzyOWq2srswcW41TyOFrarlFkx1ZPIXmGO7CH85k7cwzHsVcLY_pq9xUJS5sO0FsfdDEj1JnS20A1paS_I8roBA7nKEzmp1DisgoVZ_fxWhWOJgXejcPC9LIzCJ7kNk50vbkkvk_QU_EUE2aCqtlsE0WAS_ACSvBCR9KClymRRM3saslJIsg3c3MckgKZyQiKwxNn50BGw6XjmbjTYK-VYLXYn6l1AWWZSH4JpNuhFotoP-SC0lC11UYtizU2UbPdpEKIGtT-FFP_Z-0OKt5yMg7G_vTlCo6VqhWm0qTXUM7fP_gNhuac3WqlfgFtvJVl |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Angiotensin+II+receptor+antagonist+for+the+prevention+or+treatment+of+systemic+diseases+in+cats&rft.inventor=Stark%2C+Marcus&rft.inventor=Lang%2C+Ingo&rft.inventor=Sent%2C+Ulrike+D&rft.date=2018-04-24&rft.externalDBID=B2&rft.externalDocID=US9949954B2 |